Amgen Inc.
2 extracted findings
FDA source excerpt, selected passage
The video is misleading because it includes representations about the benefits of Vectibix but fails to communicate **any** risk information.
Findings and supporting evidence
Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.
Findings extracted from the letter
Selected FDA passages, not the complete letter.
01
The video is misleading because it includes representations about the benefits of Vectibix but fails to communicate **any** risk information.
Source passage selected by the model
02
The video is misleading because it fails to provide material information regarding Vectibix’s full FDA-approved indication, including important limitations of use.
Source passage selected by the model
Sections and clauses cited
As cited in this historical letter, not a statement of current regulatory requirements.